125 related articles for article (PubMed ID: 38575743)
41. Postoperative radiation therapy in clinical stage I endometrial cancer: corpus, cervical, and lower uterine segment involvement--patterns of failure.
Mayr NA; Wen BC; Benda JA; Sorosky JI; Davis CS; Fuller RW; Hussey DH
Radiology; 1995 Aug; 196(2):323-8. PubMed ID: 7617840
[TBL] [Abstract][Full Text] [Related]
42. Effect of surgical approach on risk of recurrence after vaginal brachytherapy in early-stage high-intermediate risk endometrial cancer.
Philp L; Tannenbaum S; Haber H; Saini A; Laurent JS; James K; Feltmate CM; Russo AL; Growdon WB
Gynecol Oncol; 2021 Feb; 160(2):389-395. PubMed ID: 33358198
[TBL] [Abstract][Full Text] [Related]
43. Prognostic significance of lymphovascular space invasion in low-risk endometrial cancer.
Ayhan A; Şahin H; Sari ME; Yalçin I; Haberal A; Meydanli MM
Int J Gynecol Cancer; 2019 Mar; 29(3):505-512. PubMed ID: 30665899
[TBL] [Abstract][Full Text] [Related]
44. Recurrence rates and patterns of recurrence in stage IA p53abn endometrial cancer with and without myometrial invasion.
Jamieson A; Grube M; Leung S; Chiu D; Lum A; Kwon JS; Talhouk A; Gilks B; Kommoss S; McAlpine JN
Int J Gynecol Cancer; 2024 Apr; 34(4):544-549. PubMed ID: 38388178
[TBL] [Abstract][Full Text] [Related]
45. PIK3CA mutations in the kinase domain (exon 20) of uterine endometrial adenocarcinomas are associated with adverse prognostic parameters.
Catasus L; Gallardo A; Cuatrecasas M; Prat J
Mod Pathol; 2008 Feb; 21(2):131-9. PubMed ID: 18084252
[TBL] [Abstract][Full Text] [Related]
46. [Metastatic mechanisms of uterine malignancies and therapeutic consequences].
Lax SF; Tamussino KF; Lang PF
Pathologe; 2016 Nov; 37(6):549-556. PubMed ID: 27757531
[TBL] [Abstract][Full Text] [Related]
47. Lymphovascular space invasion and the treatment of stage I endometrioid endometrial cancer.
van der Putten LJ; Geels YP; Ezendam NP; van der Putten HW; Snijders MP; van de Poll-Franse LV; Pijnenborg JM
Int J Gynecol Cancer; 2015 Jan; 25(1):75-80. PubMed ID: 25356534
[TBL] [Abstract][Full Text] [Related]
48. Association between tumor diameter and lymphovascular space invasion among women with early-stage endometrial cancer.
Laufer J; Scasso S; Papadia A; Sosa C; Cirillo F; Raspagliesi F
Int J Gynaecol Obstet; 2013 Nov; 123(2):142-5. PubMed ID: 23954391
[TBL] [Abstract][Full Text] [Related]
49. Stage II endometrioid adenocarcinoma of the endometrium: clinical implications of cervical stromal invasion.
Orezzoli JP; Sioletic S; Olawaiye A; Oliva E; del Carmen MG
Gynecol Oncol; 2009 Jun; 113(3):316-23. PubMed ID: 19345400
[TBL] [Abstract][Full Text] [Related]
50. Evaluation of tumor-free distance and depth of myometrial invasion as prognostic factors for lymph node metastases in endometrial cancer.
Kondalsamy-Chennakesavan S; van Vugt S; Sanday K; Nicklin J; Land R; Perrin L; Crandon A; Obermair A
Int J Gynecol Cancer; 2010 Oct; 20(7):1217-21. PubMed ID: 21495232
[TBL] [Abstract][Full Text] [Related]
51. Comparison of the laparoscopic versus conventional open method for surgical staging of endometrial carcinoma.
Chu LH; Chang WC; Sheu BC
Taiwan J Obstet Gynecol; 2016 Apr; 55(2):188-92. PubMed ID: 27125400
[TBL] [Abstract][Full Text] [Related]
52. A modern assessment of the surgical pathologic spread and nodal dissemination of endometrial cancer.
Praiss AM; Huang Y; St Clair CM; Tergas AI; Melamed A; Khoury-Collado F; Hou JY; Hur C; Ananth CV; Neugut AI; Hershman DL; Wright JD
Gynecol Oncol; 2020 May; 157(2):329-334. PubMed ID: 32094021
[TBL] [Abstract][Full Text] [Related]
53. Prospective evaluation of prognostic significance of the tumor-free distance from uterine serosa in surgically staged endometrial adenocarcinoma.
Schwab KV; O'Malley DM; Fowler JM; Copeland LJ; Cohn DE
Gynecol Oncol; 2009 Jan; 112(1):146-9. PubMed ID: 18937970
[TBL] [Abstract][Full Text] [Related]
54. Endometrial cancer in young women: prognostic factors and treatment outcomes in women aged ≤40 years.
Son J; Carr C; Yao M; Radeva M; Priyadarshini A; Marquard J; Michener CM; AlHilli M
Int J Gynecol Cancer; 2020 May; 30(5):631-639. PubMed ID: 32213530
[TBL] [Abstract][Full Text] [Related]
55. Investigating the influence of primary uterine tumor site on pelvic and para-aortic lymph node metastatic pattern and evaluating the risk factors for lymph node metastases in endometrial carcinoma: A retrospective study.
Zhang X; Chen S; Li G; Zheng L; Shang S; Li J; Guan X; Yang J
Medicine (Baltimore); 2023 Nov; 102(47):e36100. PubMed ID: 38013262
[TBL] [Abstract][Full Text] [Related]
56. The impact of lymph vascular space invasion on recurrence and survival in patients with early stage endometrial cancer.
Loizzi V; Cormio G; Lorusso M; Latorre D; Falagario M; Demitri P; Scardigno D; Selvaggi LE
Eur J Cancer Care (Engl); 2014 May; 23(3):380-4. PubMed ID: 24112088
[TBL] [Abstract][Full Text] [Related]
57. Investigation of the clinical features of lower uterine segment carcinoma: association with advanced stage disease and indication of poorer prognosis.
Miyoshi A; Kanao S; Naoi H; Otsuka H; Yokoi T
Arch Gynecol Obstet; 2018 Jan; 297(1):193-198. PubMed ID: 29116461
[TBL] [Abstract][Full Text] [Related]
58. Undifferentiated uterine carcinoma: analysis of eighteen cases.
Üreyen I; Ilgin H; Turan T; Taşçi T; Karalök A; Boran N; Özfuttu A; Tulunay G
J Obstet Gynaecol; 2015 May; 35(4):372-6. PubMed ID: 25243318
[TBL] [Abstract][Full Text] [Related]
59. Role of Adjuvant Therapy for Stage IA Serous and Clear Cell Uterine Cancer: Is Observation a Valid Strategy?
Velker V; D'Souza D; Prefontaine M; McGee J; Leung E
Int J Gynecol Cancer; 2016 Mar; 26(3):491-6. PubMed ID: 26825823
[TBL] [Abstract][Full Text] [Related]
60. Predicting Factors for Pelvic Lymph Node Metastasis in Patients with Apparently Early-Stage Endometrial Cancer.
Gumtorntip P; Poomtavorn Y; Tanprasertkul C
Asian Pac J Cancer Prev; 2022 Feb; 23(2):617-622. PubMed ID: 35225474
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
